U.S. Department of EnergyOffice of Scientific and Technical Information
Predictive and therapeutic markers in ovarian cancer
Abstract
Cancer markers may be developed to detect diseases characterized by increased expression of apoptosis-suppressing genes, such as aggressive cancers. Genes in the human chromosomal regions, 8q24, 11q13, 20q11-q13, were found to be amplified indicating in vivo drug resistance in diseases such as ovarian cancer. Diagnosis and assessment of amplification levels certain genes shown to be amplified, including PVT1, can be useful in prediction of poor outcome of patient's response and drug resistance in ovarian cancer patients with low survival rates. Certain genes were found to be high priority therapeutic targets by the identification of recurrent aberrations involving genome sequence, copy number and/or gene expression are associated with reduced survival duration in certain diseases and cancers, specifically ovarian cancer. Therapeutics to inhibit amplification and inhibitors of one of these genes, PVT1, target drug resistance in ovarian cancer patients with low survival rates is described.
- Inventors:
- Publication Date:
- Research Org.:
- Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
- Sponsoring Org.:
- USDOE
- OSTI Identifier:
- 1082960
- Patent Number(s):
- 8,404,829
- Application Number:
- 11/814,798
- Assignee:
- The Regents of the University of California (Oakland, CA) ; The Board of Regents, University of Texas System (Austin, TX)
- DOE Contract Number:
- AC02-05CH11231
- Resource Type:
- Patent
- Country of Publication:
- United States
- Language:
- English
- Subject:
- 60 APPLIED LIFE SCIENCES
Citation Formats
Gray, Joe W., Guan, Yinghui, Kuo, Wen-Lin, Fridlyand, Jane, and Mills, Gordon B. Predictive and therapeutic markers in ovarian cancer. United States: N. p., 2013.
Web.
Gray, Joe W., Guan, Yinghui, Kuo, Wen-Lin, Fridlyand, Jane, & Mills, Gordon B. Predictive and therapeutic markers in ovarian cancer. United States.
Gray, Joe W., Guan, Yinghui, Kuo, Wen-Lin, Fridlyand, Jane, and Mills, Gordon B. 2013.
"Predictive and therapeutic markers in ovarian cancer". United States. https://www.osti.gov/servlets/purl/1082960.
@article{osti_1082960,
title = {Predictive and therapeutic markers in ovarian cancer},
author = {Gray, Joe W. and Guan, Yinghui and Kuo, Wen-Lin and Fridlyand, Jane and Mills, Gordon B.},
abstractNote = {Cancer markers may be developed to detect diseases characterized by increased expression of apoptosis-suppressing genes, such as aggressive cancers. Genes in the human chromosomal regions, 8q24, 11q13, 20q11-q13, were found to be amplified indicating in vivo drug resistance in diseases such as ovarian cancer. Diagnosis and assessment of amplification levels certain genes shown to be amplified, including PVT1, can be useful in prediction of poor outcome of patient's response and drug resistance in ovarian cancer patients with low survival rates. Certain genes were found to be high priority therapeutic targets by the identification of recurrent aberrations involving genome sequence, copy number and/or gene expression are associated with reduced survival duration in certain diseases and cancers, specifically ovarian cancer. Therapeutics to inhibit amplification and inhibitors of one of these genes, PVT1, target drug resistance in ovarian cancer patients with low survival rates is described.},
doi = {},
url = {https://www.osti.gov/biblio/1082960},
journal = {},
number = ,
volume = ,
place = {United States},
year = {Tue Mar 26 00:00:00 EDT 2013},
month = {Tue Mar 26 00:00:00 EDT 2013}
}
Works referenced in this record:
Gene delivery from polymer scaffolds for tissue engineering
journal, September 2004
- Jang, Jae-Hyung; Houchin, Tiffany L.; Shea, Lonnie D.
- Expert Review of Medical Devices, Vol. 1, Issue 1
Effects of translocations on transcription from PVT.
journal, April 1990
- Shtivelman, E.; Bishop, J. M.
- Molecular and Cellular Biology, Vol. 10, Issue 4
Prospects for antiviral ribozymes and deoxyribozymes
journal, January 2004
- Peracchi, Alessio
- Reviews in Medical Virology, Vol. 14, Issue 1
Progress in Antisense Technology
journal, February 2004
- Crooke, Stanley T.
- Annual Review of Medicine, Vol. 55, Issue 1
The use of synthetic polymers for delivery of therapeutic antisense oligodeoxynucleotides
journal, January 2002
- Chirila, Traian V.; Rakoczy, Piroska E.; Garrett, Kerryn L.
- Biomaterials, Vol. 23, Issue 2
Antisense therapeutics: is it as simple as complementary base recognition?
journal, February 2000
- Agrawal, Sudhir; Kandimalla, Ekambar R.
- Molecular Medicine Today, Vol. 6, Issue 2
Nucleic-acid therapeutics: basic principles and recent applications
journal, July 2002
- Opalinska, Joanna B.; Gewirtz, Alan M.
- Nature Reviews Drug Discovery, Vol. 1, Issue 7
Identification of a commonly amplified 4.3 Mb region with overexpression of C8FW, but not MYC in MYC-containing double minutes in myeloid malignancies
journal, May 2004
- Storlazzi, C. T.
- Human Molecular Genetics, Vol. 13, Issue 14